In a subset of prostate cancers, UBE3A mediates degradation of the tumor suppressor proteins PML and p27Kip1 and thus acts as an oncogene while in non-small cell lung cancer, UBE3A acts as a tumor suppressor [300,301]. This evidence concerns the gene CDKN1B and neoplasm.